Results 11 to 20 of about 303,740 (263)
Transition from parenteral prostacyclins to selexipag: safety and feasibility in selected patients
Pulmonary Circulation, 2021 There are limited data regarding the feasibility of transitioning from intravenous prostacyclins to selexipag in pulmonary arterial hypertension patients.
Nael Aldweib +3 more
doaj +1 more source
From Hip to Heart: A Comprehensive Evaluation of an Infiltrative CardiomyopathyNovel Teaching Points
CJC Open, 2021 Infiltrative cardiomyopathies are an increasingly recognized cause of heart failure warranting systematic evaluation. Given overlap of clinical and imaging findings among etiologies of infiltrative cardiomyopathies, comprehensive evaluation, including a ...
Manavotam Singh, MD +9 more
doaj +1 more source
Advanced heart failure - a review [PDF]
Advances in Clinical and Experimental Medicine, 2019 Heart failure (HF) has been recognized as a pandemic and is a serious clinical and health problem associated with significant mortality, morbidity and expenditure on healthcare, especially among older people. Progress in medicine has made it possible for an increasing number of people with HF to live longer than ever before.
Klementyna Kępińska +2 more
openaire +2 more sources
ESC Heart Failure, 2022 Aims We present a single‐centre retrospective experience using oral milrinone in patients with a left ventricular assist device (LVAD) and concurrent refractory right ventricular failure.
Waqas Akhtar +7 more
doaj +1 more source
Natriuretic peptide biomarkers in the imminent development of preeclampsia
Frontiers in Cardiovascular Medicine, 2023 Preeclampsia is the most common cause of morbidity and mortality in pregnancy, the incidence being significantly higher in low-income countries with reduced access to health care.
Stefanie Marek-Iannucci +5 more
doaj +1 more source
Advances in diastolic heart failure
World Journal of Cardiology, 2010 More than 50% of people living with congestive heart failure have diastolic heart failure (DHF). Most of them are older than 70 years, and female. The prevalence of DHF has increased with time. DHF is caused by left ventricular (LV) diastolic dysfunction (DD) which is induced by diastolic dyssynchrony.
Xing Sheng, Yang, Jing Ping, Sun
openaire +2 more sources
Cell Transplantation, 2019 Ventricular arrhythmias (VA) are of major concern in the field of cell therapy, potentially limiting its safety and efficacy. We sought to investigate the effects of CD34 + cell therapy on VA burden in patients with chronic heart failure (CHF).
Gregor Poglajen +6 more
doaj +1 more source
IHJ Cardiovascular Case Reports, 2019 8 years boy, a case of dilated cardiomyopathy with severe biventricular dysfunction awaiting heart transplantation, sustained cardiac arrest. He was initiated on central ECMO, stabilised and then heart transplantation was performed. In the immediate post-
Babu Ezhumalai +2 more
doaj +1 more source
CardioMEMS Implantation Using Gadolinium-based Contrast Agent: A Case Report
Cardiac Failure Review, 2021 A 57-year-old woman with New York Heart Association Class III heart failure requiring multiple hospitalisations over the previous year presented for CardioMEMS implantation. Because of the patient’s allergy history of anaphylaxis to iodine-based contrast
Aniket S Rali +2 more
doaj +1 more source